Surrey Researchers Accelerate Procedures To Test And Monitor Vaccine Safety admin June 8, 2012 In the Media 0 Comments souteastIPDownload Post navigation Previous Previous post: E’ partito il progetto BioVacSafe – Biomarkers for Enhanced Vaccine Safety Università di Siena e Novartis Vaccines and Diagnostics protagonisti insieme ad altri 17 partner europeiNext Next post: IMI: 215M euros to tackle major research challenges Leave a Reply Cancel replyYou must be logged in to post a comment.
